Discovery Pharmacology Overview

Comprehensive Portfolio Reduces Risk, Lowers Cost and Speeds Discovery

With the broadest portfolio in the industry of more than 1,300 in vitro and in vivo assays, Ricerca’s discovery pharmacology capabilities help you quickly detect compounds likely to fail in the clinic and select candidates with the highest potential for success. From our modern facilities in Bothell, Washington, and Taipei, Taiwan, we provide a full range of discovery pharmacology services, including:

• Radioligand receptor binding

• Radiometric enzyme

• Cellular/functional assays

• In vitro toxicity

• OncoPanel anti-cancer screening

• ImmunoSignal biomarker services

• In vivo disease models

• In vivo safety screening models

• Foresight on-demand predictive data analysis services